NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript : vimarsana.com

NovaBay Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.95 EPS, expectations were $-0.3.

Related Keywords

United States , American , Jeffrey Cohen , Justin Hall , Jeffreyf Cohen , Tommy Law , Avenova Allograft , Jody Cain , Novabay Pharmaceuticals Fourth Quarter , Ladenburg Thalmann Company , Tommy , Novabay Pharmaceuticals Inc , Exchange Commission , Novabay Pharmaceuticals , Call Transcript March , Bay Pharmaceuticals , Full Year , Results Conference , Chief Executive Officer , General Counsel , Interim Chief Financial , Antimicrobial Lid , Lash Solution , Most Tornadoes , Ladenburg Thalmann , Edward Woo ,